Clinical trial
The Canadian Prevention of Renal and Cardiovascular Endpoints Trial
NCT00231803 · Brendan Barrett, Other · Completed
Key facts
| NCT number | NCT00231803 |
|---|---|
| Title | The Canadian Prevention of Renal and Cardiovascular Endpoints Trial |
| Official title | Canadian Collaborative Group for the Prevention of Illness in Chronic Renal Disease: The Canadian Prevention of Renal and Cardiovascular Endpoints Trial |
| Acronym | CanPrevent |
| Lead sponsor | Brendan Barrett, Other |
| Collaborators | Nova Scotia Health Authority Hopital Charles Lemoyne London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's University of British Columbia |
| Status | Completed |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Other |
| Interventions | Combined CKD and CVD Prevention, Cardiovascular Disease prevention, Treatment of Chronic Kidney Disease complications, Usual care |
| Enrollment | 474 |
| Start date | Apr 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Oct 4, 2005 |
| Last update posted | May 13, 2022 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: